Mautalen- Salud e Investigacion
CABA C1128AAF
3 studies enrolling now · 9 studies all time
What they study most
Arthritis, Rheumatoid, Bronchiectasis, Cardiovascular Diseases, Chronic Kidney Disease, Dermatitis, Atopic, Diabetes Mellitus, Type 2, Hypertension, Obesity, Plaque Psoriasis, Sjogrens Syndrome, Systemic Sclerosis
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
- A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis — Recruiting now
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease — Running, not enrolling
- A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis — Running, not enrolling
- Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
- A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis — Running, not enrolling
- A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) — Completed
- A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis — Completed